振德医疗
(603301)
| 流通市值：207.62亿 | | | 总市值：207.62亿 |
| 流通股本：2.66亿 | | | 总股本：2.66亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,184,260,011.92 | 2,100,197,326.31 | 991,564,852.44 | 4,263,886,317.39 |
| 营业收入 | 3,184,260,011.92 | 2,100,197,326.31 | 991,564,852.44 | 4,263,886,317.39 |
| 二、营业总成本 | 2,957,601,989.7 | 1,952,592,060.03 | 932,157,374.02 | 3,861,780,274.2 |
| 营业成本 | 2,103,773,741.39 | 1,382,130,817.97 | 651,676,946.14 | 2,813,364,026.6 |
| 税金及附加 | 39,807,783.22 | 26,781,276.94 | 15,783,153.35 | 40,298,036.99 |
| 销售费用 | 263,603,578.84 | 178,392,032.41 | 90,949,436.83 | 368,569,318.44 |
| 管理费用 | 424,806,793.26 | 287,009,742.65 | 134,010,474.36 | 521,609,860.99 |
| 研发费用 | 99,515,975.55 | 63,735,842.41 | 33,484,212.15 | 135,489,953.88 |
| 财务费用 | 26,094,117.44 | 14,542,347.65 | 6,253,151.19 | -17,550,922.7 |
| 其中:利息费用 | 25,032,931.45 | 13,228,489.81 | 5,406,465.13 | 28,733,061.81 |
| 其中:利息收入 | 10,497,300.64 | 4,765,356.05 | 1,769,372.4 | 24,851,303.05 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,715,586.97 | 4,795,660.88 | 3,509,377.37 | -12,245,552.1 |
| 加:投资收益 | 8,488,498.77 | 1,631,335.23 | -709,582.43 | 11,073,234.7 |
| 资产处置收益 | 921,169.55 | 340,181.43 | -4,999.99 | 93,432,002.11 |
| 资产减值损失(新) | -13,174,456.72 | -11,447,368 | -10,188,142.92 | -41,817,004.2 |
| 信用减值损失(新) | -5,361,175.31 | -4,024,468.39 | 552,909.45 | -10,231,447.63 |
| 其他收益 | 29,476,191.39 | 18,991,712 | 9,940,931.7 | 49,478,535.27 |
| 四、营业利润 | 249,723,836.87 | 157,892,319.43 | 62,507,971.6 | 491,795,811.34 |
| 加:营业外收入 | 674,073.13 | 652,775.07 | 12,078.22 | 571,817.86 |
| 减:营业外支出 | 1,569,002.4 | 1,486,163.35 | 1,126,168.67 | 16,909,056.54 |
| 五、利润总额 | 248,828,907.6 | 157,058,931.15 | 61,393,881.15 | 475,458,572.66 |
| 减:所得税费用 | 38,285,135.52 | 26,405,254.65 | 8,986,096.79 | 78,247,705.23 |
| 六、净利润 | 210,543,772.08 | 130,653,676.5 | 52,407,784.36 | 397,210,867.43 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 210,543,772.08 | 130,653,676.5 | 52,407,784.36 | 397,210,867.43 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 203,186,185.96 | 127,764,203.45 | 51,241,871.64 | 385,170,721.28 |
| 少数股东损益 | 7,357,586.12 | 2,889,473.05 | 1,165,912.72 | 12,040,146.15 |
| 扣除非经常损益后的净利润 | 182,817,829.26 | 117,983,456.29 | 47,555,148.75 | 316,398,696.81 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.76 | 0.48 | 0.19 | 1.45 |
| (二)稀释每股收益 | 0.76 | 0.48 | 0.19 | 1.45 |
| 八、其他综合收益 | 43,702,079.94 | 55,099,633.19 | 21,956,580.28 | 27,660,473.42 |
| 归属于母公司股东的其他综合收益 | 29,645,996.27 | 34,066,102.61 | 13,501,740.97 | 26,652,443.29 |
| 九、综合收益总额 | 254,245,852.02 | 185,753,309.69 | 74,364,364.64 | 424,871,340.85 |
| 归属于母公司股东的综合收益总额 | 232,832,182.23 | 161,830,306.06 | 64,743,612.61 | 411,823,164.57 |
| 归属于少数股东的综合收益总额 | 21,413,669.79 | 23,923,003.63 | 9,620,752.03 | 13,048,176.28 |
| 公告日期 | 2025-10-30 | 2025-08-28 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |